Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Liver Cells, Insulin-producing Cells, Thymus… >
Liver Cells, Insulin-producing Cells, Thymus Can Be Grown in Lymph Nodes, Pitt Team Finds

Published: September 27, 2012.
By University of Pittsburgh Schools of the Health Sciences
http://www.upmc.com/Pages/default.aspx

PITTSBURGH, Sept. 27, 2012 – Lymph nodes can provide a suitable home for a variety of cells and tissues from other organs, suggesting that a cell-based alternative to whole organ transplantation might one day be feasible, according to researchers at the University of Pittsburgh School of Medicine and its McGowan Institute for Regenerative Medicine. In a report recently published online in Nature Biotechnology, the research team showed for the first time that liver cells, thymus tissue and insulin-producing pancreatic islet cells, in an animal model, can thrive in lymph nodes despite being displaced from their natural sites.

Hepatitis virus infection, alcoholic cirrhosis and other diseases can cause so much damage that liver transplantation is the only way to save the patient, noted senior investigator Eric Lagasse, Pharm. D., Ph.D., associate professor, Department of Pathology, Pitt School of Medicine. Children with DiGeorge syndrome lack functional thymus glands to produce essential immune cells, and diabetes can be cured with a pancreas transplant.

"However, the scarcity of donor organs means many people will not survive the wait for transplantation," said Dr. Lagasse, whose lab is at the McGowan Institute. "Cell therapies are being explored, but introducing cells into tissue already ravaged by disease decreases the likelihood of successful engraftment and restoration of function."

In the study, his team tested the possibility of using lymph nodes, which are abundant throughout the body and have a rich blood supply, as a new home for cells from other organs in what is called an "ectopic" transplant.

They injected healthy liver cells from a genetically-identical donor animal into lymph nodes of mice at various locations. The result was an enlarged, liver-like node that functioned akin to the liver; in fact, a single hepatized lymph node rescued mice that were in danger of dying from a lethal metabolic liver disease. Likewise, thymus tissue transplanted into the lymph node of mice that lacked the organ generated functional immune systems, and pancreatic islet cell transplants restored normal blood sugar control in diabetic animals.

"Our goal is not necessarily to replace the entire liver, for example, but to provide sufficient cell mass to stabilize liver function and sustain the patient's life," Dr. Lagasse said. "That could buy time until a donor organ can be transplanted. Perhaps, in some cases, ectopic cell transplantation in the lymph node might allow the diseased organ to recover."




Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Tolerance 
5/24/10 
Gene Pattern May Identify Kidney Transplant Recipients Who Don't Need Life-long Anti-rejection Drugs
By National Institute of Allergy and Infectious Diseases
Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped …
Drugs 
5/24/10 
Gene Pattern May Identify Kidney Transplant Recipients Who Don't Need Lifelong Anti-rejection Drugs
By Emory University
To prevent rejection of their new kidneys, kidney transplant recipients need to take immunosuppressive drugs for the rest of their lives. A handful of people, out of the thousands …
Tolerance 
1/9/14 
Mass. General Research Could Expand Availability of Hand, Face Transplants
By Massachusetts General Hospital
Massachusetts General Hospital (MGH) investigators have made an important step towards greater availability of hand transplants, face transplants and other transplants involving multiple types of tissue. In their report …
Cells 
5/27/10 
Color-coded Tracking Method Helps Scientists Analyze Outcomes of Newly Transplanted Tissue
By Beth Israel Deaconess Medical Center
BOSTON – A group of "color-coded" laboratory mice are providing researchers with a novel way of tracking T-cells, enabling them to visualize and monitor the cellular immune responses of …
Lung 
2/25/14 
★★★ 

New Clues Found to Preventing Lung Transplant Rejection
By Washington University School of Medicine
Cells 
9/1/11 
New Half-match Bone Marrow Transplant Procedure Yields Promising Outcomes for Cancer Patients
By Thomas Jefferson University
PHILADELPHIA—Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center …
Cells 
1/17/14 
New Insights into Facial Transplantation
By Brigham and Women's Hospital
Boston, MA—In 2009, the first face transplant was performed at Brigham and Women's Hospital (BWH), and lead surgeon, Dr. Bohdan Pomahac has been pioneering the procedure since. However, understanding …
Immune 
4/29/10 
Study Links Liver Transplantation to Accelerated Cellular Aging
By Wiley-Blackwell
Researchers at the University of Cambridge found that liver transplant recipients develop premature immune senescence, the normal process by which the immune system ages and becomes less effective. Full …
Lymphocytes 
11/18/14 
Avoiding Skin Graft Rejection: It's Possible!
By INSERM (Institut national de la santé et de la recherche médicale)
A research team bringing together José Cohen and Philippe Grimbert (Inserm Unit 955/Université Paris Est Créteil UPEC and the Centre for Clinical Investigation - Biotherapies 504 [CIC-BT 504]), and …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition